Hollsteen
← MACOM

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $419M · 10-Q 0001193125-16-439832 filed Jan 27, 2016Equity incl. NCI · Q2 FY2016: $414M · 10-Q 0001193125-16-559543 filed Apr 27, 2016Equity incl. NCI · Q3 FY2016: $447M · 10-Q 0001493594-16-000007 filed Jul 27, 2016Equity incl. NCI · Q4 FY2016: $463M · 10-K 0001493594-16-000016 filed Nov 17, 2016Equity incl. NCI · Q1 FY2017: $463M · 10-Q 0001493594-17-000012 filed Feb 1, 2017Equity incl. NCI · Q2 FY2017: $800M · 10-Q 0001493594-17-000037 filed Apr 26, 2017Equity incl. NCI · Q3 FY2017: $779M · 10-Q 0001493594-17-000046 filed Aug 2, 2017Equity incl. NCI · Q4 FY2017: $777M · 10-K 0001493594-17-000055 filed Nov 15, 2017Equity incl. NCI · Q1 FY2018: $768M · 10-Q 0001493594-18-000008 filed Feb 7, 2018Equity incl. NCI · Q2 FY2018: $758M · 10-Q 0001493594-19-000051 filed Aug 6, 2019Equity incl. NCI · Q3 FY2018: $679M · 10-Q 0001493594-18-000026 filed Aug 1, 2018Equity incl. NCI · Q4 FY2018: $669M · 10-K 0001493594-18-000034 filed Nov 16, 2018Equity incl. NCI · Q1 FY2019: $657M · 10-Q 0001493594-19-000008 filed Feb 6, 2019Equity incl. NCI · Q2 FY2019: $617M · 10-Q 0001493594-19-000022 filed May 8, 2019Equity incl. NCI · Q3 FY2019: $299M · 10-Q 0001493594-19-000051 filed Aug 6, 2019Equity incl. NCI · Q4 FY2019: $314M · 10-K 0001493594-19-000064 filed Nov 26, 2019Equity incl. NCI · Q1 FY2020: $294M · 10-Q 0001493594-20-000017 filed Jan 29, 2020Equity incl. NCI · Q2 FY2020: $286M · 10-Q 0001493594-20-000037 filed Apr 30, 2020Equity incl. NCI · Q3 FY2020: $273M · 10-Q 0001493594-20-000051 filed Jul 30, 2020Equity incl. NCI · Q4 FY2020: $300M · 10-K 0001493594-20-000063 filed Nov 18, 2020Equity incl. NCI · Q1 FY2021: $329M · 10-Q 0001493594-21-000014 filed Jan 28, 2021Equity incl. NCI · Q2 FY2021: $412M · 10-Q 0001493594-21-000056 filed Apr 29, 2021Equity incl. NCI · Q3 FY2021: $446M · 10-Q 0001493594-21-000072 filed Jul 29, 2021Equity incl. NCI · Q4 FY2021: $472M · 10-K 0001493594-21-000079 filed Nov 15, 2021Equity incl. NCI · Q1 FY2022: $525M · 10-Q 0001493594-22-000011 filed Jan 27, 2022Equity incl. NCI · Q2 FY2022: $554M · 10-Q 0001493594-22-000025 filed Apr 28, 2022Equity incl. NCI · Q3 FY2022: $596M · 10-Q 0001493594-22-000037 filed Jul 28, 2022Equity incl. NCI · Q4 FY2022: $843M · 10-K 0001493594-22-000047 filed Nov 14, 2022Equity incl. NCI · Q1 FY2023: $863M · 10-Q 0001493594-23-000035 filed Feb 2, 2023Equity incl. NCI · Q2 FY2023: $894M · 10-Q 0001493594-23-000046 filed May 4, 2023Equity incl. NCI · Q3 FY2023: $915M · 10-Q 0001493594-23-000057 filed Aug 3, 2023Equity incl. NCI · Q4 FY2023: $948M · 10-K 0001493594-23-000081 filed Nov 13, 2023Equity incl. NCI · Q1 FY2024: $1.0B · 10-Q 0001493594-24-000028 filed Feb 1, 2024Equity incl. NCI · Q2 FY2024: $1.0B · 10-Q 0001493594-24-000040 filed May 2, 2024Equity incl. NCI · Q3 FY2024: $1.1B · 10-Q 0001493594-24-000052 filed Aug 1, 2024Equity incl. NCI · Q4 FY2024: $1.1B · 10-K 0001493594-24-000060 filed Nov 12, 2024Equity incl. NCI · Q1 FY2025: $1.2B · 10-Q 0001493594-25-000020 filed Feb 6, 2025Equity incl. NCI · Q2 FY2025: $1.2B · 10-Q 0001493594-25-000029 filed May 8, 2025Equity incl. NCI · Q3 FY2025: $1.3B · 10-Q 0001493594-25-000038 filed Aug 7, 2025Equity incl. NCI · Q4 FY2025: $1.3B · 10-K 0001493594-25-000054 filed Nov 14, 2025Equity incl. NCI · Q1 FY2026: $1.4B · 10-Q 0001493594-26-000019 filed Feb 5, 2026Equity incl. NCI · Q2 FY2026: $1.4B · 10-Q 0001493594-26-000028 filed May 7, 2026Equity incl. NCI · Q3 FY2026: $1.5B · 10-Q 0001493594-26-000038 filed Aug 6, 20261,0241,541419Q1 FY2016Q3 FY2026Q1 FY2024
Q1 FY2024
1,024$M
All values (43)
PeriodValue ($M)Status
Q3 FY20261,541reported
Q2 FY20261,418reported
Q1 FY20261,353reported
Q4 FY20251,327reported
Q3 FY20251,263reported
Q2 FY20251,202reported
Q1 FY20251,151reported
Q4 FY20241,126reported
Q3 FY20241,081reported
Q2 FY20241,046reported
Q1 FY20241,024reported
Q4 FY2023948reported
Q3 FY2023915reported
Q2 FY2023894reported
Q1 FY2023863reported
Q4 FY2022843reported
Q3 FY2022596reported
Q2 FY2022554reported
Q1 FY2022525reported
Q4 FY2021472reported
Q3 FY2021446reported
Q2 FY2021412reported
Q1 FY2021329reported
Q4 FY2020300reported
Q3 FY2020273reported
Q2 FY2020286reported
Q1 FY2020294reported
Q4 FY2019314reported
Q3 FY2019299reported
Q2 FY2019617reported
Q1 FY2019657reported
Q4 FY2018669reported
Q3 FY2018679reported
Q2 FY2018758reported
Q1 FY2018768reported
Q4 FY2017777reported
Q3 FY2017779reported
Q2 FY2017800reported
Q1 FY2017463reported
Q4 FY2016463reported
Q3 FY2016447reported
Q2 FY2016414reported
Q1 FY2016419reported

CSV with all sources · Technical ID: equity_total

More metrics for MACOM
Sources & calculation
Value
$1.0B
Period
Q1 FY2024, ended Dec 29, 2023 · as of Dec 29, 2023 (balance as of date, not a sum)
Source
10-Q, filed Feb 1, 2024 · 0001493594-24-000028
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.0BFeb 1, 202410-Q 0001493594-24-000028reported · confidence 1. · current